Gts Securities LLC Inhibrx, Inc. Transaction History
Gts Securities LLC
- $45.4 Billion
- Q3 2024
A detailed history of Gts Securities LLC transactions in Inhibrx, Inc. stock. As of the latest transaction made, Gts Securities LLC holds 8,000 shares of INBX stock, worth $115,760. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,000Holding current value
$115,760% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding INBX
# of Institutions
1Shares Held
18.6KCall Options Held
0Put Options Held
0About Inhibrx, Inc.
- Ticker INBX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,057,700
- Market Cap $565M
- Description
- Inhibrx, Inc., a clinical-stage biotechnology company, focuses on developing a pipeline of novel biologic therapeutic candidates. The company's therapeutic candidates include INBRX-109, a tetravalent agonist of death receptor 5, which is in Phase 2 clinical trials to treat cancers, such as chondrosarcoma, mesothelioma, and pancreatic adenocarcin...